BioBridgeXAll companies

Khloris Biosciences, Inc.

Pharmaceutical company · South San Francisco, California, United States

Khloris Biosciences, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2017. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.7 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $5 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Khloris Biosciences at a glance

Typepharmaceutical company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2017
Employees (self-reported, 2022)2
SEC CIK1760227

What does Khloris Biosciences do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $1.7 million in total (2022). NIH funding came from the National Heart, Lung, and Blood Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $5 million sold (2018).

Frequently asked questions about Khloris Biosciences

Where is Khloris Biosciences headquartered?

Khloris Biosciences, Inc. is headquartered in South San Francisco, California, United States.

What does Khloris Biosciences do?

Khloris Biosciences, Inc. is a pharmaceutical company.

When was Khloris Biosciences founded?

The earliest incorporation on record for Khloris Biosciences, Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences